FONR
FONAR CORP
Key Financials
Net Income
$8.3M
↓ 21.1%
Revenue
$104.4M
↑ 1.4%
Operating Income
$4.5M
↓ 59.4%
EPS (Diluted)
$0.86
↑ 177.4%
Total Assets
$216.9M
↑ 1.2%
Cash & Equivalents
$56.3M
↓ 0.0%
Shareholders' Equity
$172.6M
↑ 4.0%
Total Liabilities
$56.8M
↓ 1.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 6/15/2026 | View on SEC |
| SCHEDULE 13G | 6/10/2026 | View on SEC |
| 4 | 6/9/2026 | View on SEC |
| 3 | 6/9/2026 | View on SEC |
| 4 | 6/9/2026 | View on SEC |
| 4 | 6/9/2026 | View on SEC |
| 3 | 6/9/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 3 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FONR |
| Company Name | FONAR CORP |
| CIK | 355019 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 6316942929 |